 | • レポートコード：GIR201104445 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、女性用避妊薬の世界市場を調査対象にし、女性用避妊薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他）、用途別分析（クリニック、病院、ホームケア）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Addex Therapeutics Ltd、Teva Pharmaceutical Industries Ltd、Evofem Inc、Agile Therapeutics Inc、Orbis Biosciences Inc、Bayer AG、Mithra Pharmaceuticals SA、Hervana Ltd、Viramal Ltd ・メーカー別販売量、売上、市場シェア ・女性用避妊薬の地域別市場分析 ・女性用避妊薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・女性用避妊薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・女性用避妊薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・女性用避妊薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・女性用避妊薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・女性用避妊薬の種類別市場規模2015-2020：AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他 ・女性用避妊薬の用途別市場規模2015-2020：クリニック、病院、ホームケア ・女性用避妊薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Female Contraception Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Female Contraception Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Female Contraception Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Female Contraception Drug market has been segmented into
AG-890
Amphora
BAY-1007626
Drospirenone
Others
By Application, Female Contraception Drug has been segmented into:
Clinic
Hospital
Homecare
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Female Contraception Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Female Contraception Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Female Contraception Drug market.
The report offers in-depth assessment of the growth and other aspects of the Female Contraception Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Female Contraception Drug Market Share Analysis
Female Contraception Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Female Contraception Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Female Contraception Drug sales, revenue and market share for each player covered in this report.
The major players covered in Female Contraception Drug are:
Addex Therapeutics Ltd
Teva Pharmaceutical Industries Ltd
Evofem Inc
Agile Therapeutics Inc
Orbis Biosciences Inc
Bayer AG
Mithra Pharmaceuticals SA
Hervana Ltd
Viramal Ltd
Among other players domestic and global, Female Contraception Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Female Contraception Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Female Contraception Drug, with price, sales, revenue and global market share of Female Contraception Drug in 2018 and 2019.
Chapter 3, the Female Contraception Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Female Contraception Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Female Contraception Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Female Contraception Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Female Contraception Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Female Contraception Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Female Contraception Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Overview of Global Female Contraception Drug Market
1.4.1 Global Female Contraception Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Addex Therapeutics Ltd
2.1.1 Addex Therapeutics Ltd Details
2.1.2 Addex Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Addex Therapeutics Ltd SWOT Analysis
2.1.4 Addex Therapeutics Ltd Product and Services
2.1.5 Addex Therapeutics Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva Pharmaceutical Industries Ltd
2.2.1 Teva Pharmaceutical Industries Ltd Details
2.2.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.2.4 Teva Pharmaceutical Industries Ltd Product and Services
2.2.5 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Evofem Inc
2.3.1 Evofem Inc Details
2.3.2 Evofem Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Evofem Inc SWOT Analysis
2.3.4 Evofem Inc Product and Services
2.3.5 Evofem Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agile Therapeutics Inc
2.4.1 Agile Therapeutics Inc Details
2.4.2 Agile Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agile Therapeutics Inc SWOT Analysis
2.4.4 Agile Therapeutics Inc Product and Services
2.4.5 Agile Therapeutics Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Orbis Biosciences Inc
2.5.1 Orbis Biosciences Inc Details
2.5.2 Orbis Biosciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Orbis Biosciences Inc SWOT Analysis
2.5.4 Orbis Biosciences Inc Product and Services
2.5.5 Orbis Biosciences Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer AG SWOT Analysis
2.6.4 Bayer AG Product and Services
2.6.5 Bayer AG Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mithra Pharmaceuticals SA
2.7.1 Mithra Pharmaceuticals SA Details
2.7.2 Mithra Pharmaceuticals SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mithra Pharmaceuticals SA SWOT Analysis
2.7.4 Mithra Pharmaceuticals SA Product and Services
2.7.5 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hervana Ltd
2.8.1 Hervana Ltd Details
2.8.2 Hervana Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hervana Ltd SWOT Analysis
2.8.4 Hervana Ltd Product and Services
2.8.5 Hervana Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Viramal Ltd
2.9.1 Viramal Ltd Details
2.9.2 Viramal Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Viramal Ltd SWOT Analysis
2.9.4 Viramal Ltd Product and Services
2.9.5 Viramal Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Female Contraception Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Female Contraception Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Female Contraception Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Female Contraception Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Female Contraception Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Female Contraception Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Female Contraception Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Female Contraception Drug Sales and Growth Rate (2015-2020)
4.3 Europe Female Contraception Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Female Contraception Drug Sales and Growth Rate (2015-2020)
4.5 South America Female Contraception Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Female Contraception Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Female Contraception Drug Sales, Revenue and Market Share by Country
5.1.1 North America Female Contraception Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Female Contraception Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Female Contraception Drug Sales and Growth Rate (2015-2020)
5.3 Canada Female Contraception Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Female Contraception Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Female Contraception Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Female Contraception Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Female Contraception Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Female Contraception Drug Sales and Growth Rate (2015-2020)
6.3 UK Female Contraception Drug Sales and Growth Rate (2015-2020)
6.4 France Female Contraception Drug Sales and Growth Rate (2015-2020)
6.5 Russia Female Contraception Drug Sales and Growth Rate (2015-2020)
6.6 Italy Female Contraception Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Female Contraception Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Female Contraception Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Female Contraception Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Female Contraception Drug Sales and Growth Rate (2015-2020)
7.3 Japan Female Contraception Drug Sales and Growth Rate (2015-2020)
7.4 Korea Female Contraception Drug Sales and Growth Rate (2015-2020)
7.5 India Female Contraception Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Female Contraception Drug Sales and Growth Rate (2015-2020)
7.7 Australia Female Contraception Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Female Contraception Drug Sales, Revenue and Market Share by Country
8.1.1 South America Female Contraception Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Female Contraception Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Female Contraception Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Female Contraception Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Female Contraception Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Female Contraception Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Female Contraception Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Female Contraception Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Female Contraception Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Female Contraception Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Female Contraception Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Female Contraception Drug Sales and Market Share by Type (2015-2020)
10.2 Global Female Contraception Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Female Contraception Drug Price by Type (2015-2020)
11 Global Female Contraception Drug Market Segment by Application
11.1 Global Female Contraception Drug Sales Market Share by Application (2015-2020)
11.2 Global Female Contraception Drug Revenue Market Share by Application (2015-2020)
11.3 Global Female Contraception Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Female Contraception Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Female Contraception Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Female Contraception Drug Market Forecast (2021-2025)
12.2.2 Europe Female Contraception Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Female Contraception Drug Market Forecast (2021-2025)
12.2.4 South America Female Contraception Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Female Contraception Drug Market Forecast (2021-2025)
12.3 Female Contraception Drug Market Forecast by Type (2021-2025)
12.3.1 Global Female Contraception Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Female Contraception Drug Market Share Forecast by Type (2021-2025)
12.4 Female Contraception Drug Market Forecast by Application (2021-2025)
12.4.1 Global Female Contraception Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Female Contraception Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Female Contraception Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Female Contraception Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Female Contraception Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Addex Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Addex Therapeutics Ltd Female Contraception Drug Major Business
Table 9. Addex Therapeutics Ltd Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 10. Addex Therapeutics Ltd SWOT Analysis
Table 11. Addex Therapeutics Ltd Female Contraception Drug Product and Services
Table 12. Addex Therapeutics Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Ltd Female Contraception Drug Major Business
Table 15. Teva Pharmaceutical Industries Ltd Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 16. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 17. Teva Pharmaceutical Industries Ltd Female Contraception Drug Product and Services
Table 18. Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Evofem Inc Basic Information, Manufacturing Base and Competitors
Table 20. Evofem Inc Female Contraception Drug Major Business
Table 21. Evofem Inc Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 22. Evofem Inc SWOT Analysis
Table 23. Evofem Inc Female Contraception Drug Product and Services
Table 24. Evofem Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Agile Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 26. Agile Therapeutics Inc Female Contraception Drug Major Business
Table 27. Agile Therapeutics Inc Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 28. Agile Therapeutics Inc SWOT Analysis
Table 29. Agile Therapeutics Inc Female Contraception Drug Product and Services
Table 30. Agile Therapeutics Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Orbis Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 32. Orbis Biosciences Inc Female Contraception Drug Major Business
Table 33. Orbis Biosciences Inc Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 34. Orbis Biosciences Inc SWOT Analysis
Table 35. Orbis Biosciences Inc Female Contraception Drug Product and Services
Table 36. Orbis Biosciences Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 38. Bayer AG Female Contraception Drug Major Business
Table 39. Bayer AG Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 40. Bayer AG SWOT Analysis
Table 41. Bayer AG Female Contraception Drug Product and Services
Table 42. Bayer AG Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mithra Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 44. Mithra Pharmaceuticals SA Female Contraception Drug Major Business
Table 45. Mithra Pharmaceuticals SA Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 46. Mithra Pharmaceuticals SA SWOT Analysis
Table 47. Mithra Pharmaceuticals SA Female Contraception Drug Product and Services
Table 48. Mithra Pharmaceuticals SA Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Hervana Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Hervana Ltd Female Contraception Drug Major Business
Table 51. Hervana Ltd Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 52. Hervana Ltd SWOT Analysis
Table 53. Hervana Ltd Female Contraception Drug Product and Services
Table 54. Hervana Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Viramal Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Viramal Ltd Female Contraception Drug Major Business
Table 57. Viramal Ltd Female Contraception Drug Total Revenue (USD Million) (2018-2019)
Table 58. Viramal Ltd SWOT Analysis
Table 59. Viramal Ltd Female Contraception Drug Product and Services
Table 60. Viramal Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Female Contraception Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global Female Contraception Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Female Contraception Drug Sales by Regions (2015-2020) (K Pcs)
Table 64. Global Female Contraception Drug Sales Market Share by Regions (2015-2020)
Table 65. Global Female Contraception Drug Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Female Contraception Drug Sales by Countries (2015-2020) (K Pcs)
Table 67. North America Female Contraception Drug Sales Market Share by Countries (2015-2020)
Table 68. North America Female Contraception Drug Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Female Contraception Drug Revenue Market Share by Countries (2015-2020)
Table 70. Europe Female Contraception Drug Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe Female Contraception Drug Sales Market Share by Countries (2015-2020)
Table 72. Europe Female Contraception Drug Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Female Contraception Drug Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific Female Contraception Drug Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Female Contraception Drug Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Female Contraception Drug Sales by Countries (2015-2020) (K Pcs)
Table 77. South America Female Contraception Drug Sales Market Share by Countries (2015-2020)
Table 78. South America Female Contraception Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Female Contraception Drug Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Female Contraception Drug Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa Female Contraception Drug Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Female Contraception Drug Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Female Contraception Drug Revenue Market Share by Countries (2015-2020)
Table 84. Global Female Contraception Drug Sales by Type (2015-2020) (K Pcs)
Table 85. Global Female Contraception Drug Sales Share by Type (2015-2020)
Table 86. Global Female Contraception Drug Revenue by Type (2015-2020) (USD Million)
Table 87. Global Female Contraception Drug Revenue Share by Type (2015-2020)
Table 88. Global Female Contraception Drug Sales by Application (2015-2020) (K Pcs)
Table 89. Global Female Contraception Drug Sales Share by Application (2015-2020)
Table 90. Global Female Contraception Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global Female Contraception Drug Market Share Forecast by Regions (2021-2025)
Table 92. Global Female Contraception Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global Female Contraception Drug Market Share Forecast by Type (2021-2025)
Table 94. Global Female Contraception Drug Sales Forecast by Application (2021-2025)
Table 95. Global Female Contraception Drug Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Female Contraception Drug Picture
Figure 2. Global Sales Market Share of Female Contraception Drug by Type in 2019
Figure 3. AG-890 Picture
Figure 4. Amphora Picture
Figure 5. BAY-1007626 Picture
Figure 6. Drospirenone Picture
Figure 7. Others Picture
Figure 8. Female Contraception Drug Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Homecare Picture
Figure 12. Global Female Contraception Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Female Contraception Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Female Contraception Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Female Contraception Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Female Contraception Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Female Contraception Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Female Contraception Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Female Contraception Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Female Contraception Drug Revenue Market Share by Regions in 2018
Figure 41. North America Female Contraception Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Female Contraception Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Female Contraception Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Female Contraception Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Female Contraception Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Female Contraception Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Female Contraception Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Female Contraception Drug Sales Market Share by Countries in 2018
Figure 49. North America Female Contraception Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Female Contraception Drug Revenue Market Share by Countries in 2018
Figure 51. United States Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Female Contraception Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Female Contraception Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Female Contraception Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Female Contraception Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Female Contraception Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Female Contraception Drug Revenue Market Share by Regions 2019
Figure 65. China Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Female Contraception Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Female Contraception Drug Sales Market Share by Countries in 2019
Figure 72. South America Female Contraception Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Female Contraception Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Female Contraception Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Female Contraception Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Female Contraception Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Female Contraception Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Female Contraception Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Female Contraception Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Female Contraception Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Female Contraception Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Female Contraception Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Female Contraception Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Female Contraception Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
女性用コンドームの世界市場 2020年 Market Overview The global Female Condoms market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Condoms market report p…- 女性用性的欲求低下障害治療薬の世界市場 2020年 Market Overview The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…
- 女性用性具の世界市場 2020年 Market Overview The global Female Sex Toys market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Sex Toys market report…
- 女性用脱毛製品の世界市場 2020年 Market Overview The global Female Depilatory Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Depilatory …
- 女性生殖能力・妊娠迅速検査の世界市場 2020年 Market Overview The global Female Fertility and Pregnancy Rapid Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 423.1 million by 2025, from USD 368.9 million in 2019. …